### ğŸ“„ Trans-ancestry GWAS identifies 59 loci and improves risk prediction and fine-mapping for kidney stone disease
**åŸæ–‡é“¾æ¥**: https://www.nature.com/articles/s41467-025-58782-7 ï¼ˆDOI: 10.1038/s41467-025-58782-7ï¼‰ \
**ä½œè€…**: Xi Cao, Minghui Jiang, Yunlong Guan, et al.  \
**æœŸåˆŠ**: *Nat Commun*, 2025 \
**å…³é”®è¯**: GWAS, population stratification, mixed models, ancestry correction, cryptic relatedness  

---

## ğŸ§  ä¸€ã€ç ”ç©¶èƒŒæ™¯

- è‚¾ç»“çŸ³ç–¾ç—…ï¼ˆKidney Stone Disease, KSDï¼‰æ˜¯ä¸€ä¸ªå¤æ‚ã€å¤šå› ç´ é©±åŠ¨çš„ç–¾ç—…ï¼Œå—é—ä¼ ã€ä»£è°¢ã€ç¯å¢ƒç­‰å¤šç§å› ç´ å½±å“ã€‚
- è™½ç„¶å·²æœ‰è‹¥å¹² GWAS æ¢ç´¢ KSD çš„é£é™©å˜å¼‚ï¼Œä½†å¤šæ•°ç ”ç©¶é™äºå•ä¸€ç¥–æºäººç¾¤ï¼Œè¿™å¯èƒ½é™åˆ¶å‘ç°å˜å¼‚çš„è·¨äººç¾¤é€šç”¨æ€§ä¸æ•ˆæœã€‚
- è·¨ç¥–æº GWASï¼ˆtrans-ancestry GWASï¼‰èƒ½å¤Ÿåˆ©ç”¨ä¸åŒäººç¾¤çš„ LD ç»“æ„å·®å¼‚ï¼Œæé«˜æ£€æµ‹åŠŸç‡ã€æ”¹å–„ä¿¡å·å®šä½ä¸ç»†åŒ–å˜å¼‚è¯†åˆ«ã€‚  
- æ­¤å¤–ï¼Œé€šè¿‡æ›´ç²¾ç¡®çš„ fine-mapping é©±åŠ¨å› æœå˜å¼‚è¯†åˆ«ï¼Œä»¥åŠæ„å»ºè·¨äººç¾¤æœ‰æ•ˆçš„ polygenic risk score (PRS) æ¨¡å‹ï¼Œæ˜¯æœ¬ç ”ç©¶çš„ä¸»è¦ç›®æ ‡ä¹‹ä¸€ã€‚

---

## ğŸ”¬ äºŒã€ç ”ç©¶æ–¹æ³•ï¼ˆç»¼è¿°ä¸­è®¨è®ºçš„æ–¹æ³•ï¼‰

| æ¨¡å— | æ–¹æ³• / ç­–ç•¥ | è¯´æ˜ / å…³é”®ç‚¹ |
|---|-------------------------|-----------------------------|
| **è·¨ç¥–æº Meta-åˆ†æ (Trans-ancestry GWAS meta-analysis)** | å°†æ¬§æ´² (EUR) ä¸ä¸œäºš (EAS) äººç¾¤çš„ GWAS æ•°æ®åˆå¹¶åš meta åˆ†æ | æ ·æœ¬é‡ï¼š31,715 ä¾‹ + 943,655 å¯¹ç…§ï¼ˆEUR + EASï¼‰|
| **æ˜¾è‘—ä½ç‚¹é‰´å®š** | åœ¨ meta åˆ†æç»“æœä¸­è¯†åˆ«æ˜¾è‘—é£é™©ä½ç‚¹ï¼ˆP < 5Ã—10â»â¸ï¼‰ï¼Œå…±å¾—åˆ° 59 ä¸ªç‹¬ç«‹ä½ç‚¹ï¼Œå…¶ä¸­ 13 ä¸ªä¸ºæ–°å‘ç° | è¿™äº›ä½ç‚¹åœ¨ EUR å’Œ EAS äººç¾¤ä¸­çš„æ•ˆåº”æ–¹å‘ä¸€è‡´æ€§è¾ƒé«˜ |
| **Fine-mapping / å› æœä¿¡å·å®šä½** | åœ¨æ¯ä¸ªé£é™©ä½ç‚¹åšç²¾ç»†å®šä½ (credible set / posterior inclusion probability, PIP) åˆ†æ | å…±æ£€æµ‹åˆ° 1,612 ä¸ªå€™é€‰å˜å¼‚ï¼Œå¹¶åœ¨å…¶ä¸­å®šä½å‡º 25 ä¸ªå…·æœ‰ PIP > 0.5 çš„å› æœä¿¡å· |
| **ä¼˜å…ˆåŸºå› è¯†åˆ« / ç”Ÿç‰©æ³¨é‡Š** | åœ¨æ–°ä½ç‚¹ä¸­æŒ‡å‡º TRIOBP åŸºå› ä½œä¸ºä¸€ä¸ªå¯èƒ½å…³è”åŸºå› ï¼ˆåœ¨æŸäº›ä½ç‚¹ï¼‰ | ä½œè€…å¯¹ TRIOBP åŸºå› åŠå…¶å¯èƒ½çš„ç”Ÿç‰©å­¦æœºåˆ¶åšäº†è®¨è®º |
| **è·¨äººç¾¤ PRS æ„å»ºä¸è¯„ä¼°** | ä½¿ç”¨ PRS-CSxï¼ˆè·¨äººç¾¤ PRS æ–¹æ³•ï¼‰æ„å»º EAS + EUR çš„è”åˆ PRS æ¨¡å‹ | è¯¥æ¨¡å‹ä¼˜äºå…¶ä»– PRS æ„å»ºæ–¹æ³•ï¼Œåœ¨ä¸åŒäººç¾¤ä¸­é¢„æµ‹æ€§èƒ½æ›´ä½³ |
| **é£é™©åˆ†å±‚ / æ•ˆæœä¼°è®¡** | å°†æ ·æœ¬æŒ‰ PRS åˆ†ä½æ•°åˆ†ç»„ï¼Œæ¯”è¾ƒæœ€ä½ä¸æœ€é«˜ç»„çš„ KSD é£é™©æ¯” (odds ratios) | ç›¸å¯¹äºä¸­é—´ä¸‰åˆ†ä½ç»„ï¼Œæœ€ä½ç»„ OR ~0.57ï¼Œæœ€é«˜ç»„ OR ~1.83 ç­‰ |
| **å¹´é¾„å‘ç—… / è¡¨å‹å…³è”åˆ†æ** | æ£€éªŒé«˜ PRS äººç¾¤æ˜¯å¦æœ‰æ›´æ—©å‘ç—…å€¾å‘ç­‰ | ç»“æœè¡¨æ˜ï¼šè¾ƒé«˜ PRS çš„æ‚£è€…å‘ç—…å¹´é¾„å¯èƒ½æ›´å¹´è½» |

---

## ğŸ§© ä¸‰ã€ä¸»è¦å‘ç°

1. **è¯†åˆ« 59 ä¸ªè‚¾ç»“çŸ³å…³è”ä½ç‚¹**  
   åŒ…æ‹¬ 13 ä¸ªæ­¤å‰æœªæŠ¥é“çš„æ–°ä½ç‚¹ï¼Œä¸”å¤§å¤šæ•°åœ¨ EUR å’Œ EAS ä¸­æ•ˆåº”æ–¹å‘ä¸€è‡´ã€‚ 
2. **Fine-mapping å®šä½åˆ° 25 ä¸ªé«˜ç½®ä¿¡å› æœä¿¡å·**  
   åœ¨å¤šä¸ªé£é™©ä½ç‚¹ä¸­æˆåŠŸå°†å€™é€‰å˜å¼‚ç¼©å‡åˆ°è¾ƒå° credible setï¼Œå¹¶è¯†åˆ«å‡º PIP > 0.5 çš„å› æœå€™é€‰ã€‚
3. **ä¼˜å…ˆåŸºå›  TRIOBP**  
   åœ¨ä¸€ä¸ªæ–°ä½ç‚¹ä¸­ï¼Œä½œè€…ä¼˜å…ˆå°† TRIOBP ä½œä¸ºå¯èƒ½çš„è‡´ç—…åŸºå› ä¹‹ä¸€ï¼Œç»“åˆå…¶ç”Ÿç‰©å­¦èƒŒæ™¯è¿›è¡Œæ¨æµ‹ã€‚
4. **è·¨äººç¾¤ PRS è¡¨ç°æå‡**  
   ä½¿ç”¨ PRS-CSxï¼ˆç»“åˆ EAS + EUR æ•°æ®ï¼‰æ„å»ºçš„è”åˆ PRS åœ¨é¢„æµ‹æ•ˆæœä¸Šä¼˜äºå•ä¸€äººç¾¤æ„å»ºçš„æ¨¡å‹ã€‚
5. **é£é™©åˆ†ä½æ•°å·®å¼‚å¼ºçƒˆ**  
   ç›¸æ¯”äºä¸­é—´ç»„ï¼Œæœ€ä½ PRS ç»„ä¸æœ€é«˜ç»„åœ¨ KSD é£é™©ä¸Šæœ‰æ˜¾è‘—å·®å¼‚ï¼ˆOR çº¦ 0.57 vs 1.83ï¼‰
6. **å‘ç—…å¹´é¾„å…³è”**  
   è¾ƒé«˜ PRS çš„ KSD æ‚£è€…å€¾å‘äºè¾ƒæ—©å‘ç—…ï¼Œè¿™æç¤º PRS åœ¨ç–¾ç—…è¿›å±• /é¢„åå±‚é¢å¯èƒ½ä¹Ÿæœ‰æ„ä¹‰ã€‚

---

## ğŸ’¬ å››ã€ä¸ªäººç†è§£ä¸å¯å‘
- è¿™ç¯‡ç ”ç©¶æ˜¯è·¨ç¥–æº GWAS åœ¨å…·ä½“ç–¾ç—…åº”ç”¨ä¸Šçš„å…¸èŒƒï¼šä¸ä»…è¿›è¡Œäº† meta åˆ†æï¼Œè¿˜æŠŠ fine-mappingã€è·¨äººç¾¤ PRSã€é£é™©å»ºæ¨¡éƒ½æ•´åˆè¿›æ¥ã€‚  
- å¯¹åšç±»ä¼¼é¡¹ç›®çš„å¯å‘åŒ…æ‹¬ï¼š  
  - å¦‚æœæœ‰å¤šä¸ªäººç¾¤çš„ GWAS æ•°æ®ï¼Œå¯ä»¥å°è¯•è·¨ç¥–æº meta åˆ†æä»¥æé«˜åŠŸæ•ˆä¸é€šç”¨æ€§ï¼›  
  - åœ¨è¯†åˆ«ä¿¡å·ä¹‹ååš fine-mapping æ˜¯å…³é”®ï¼Œå¯¹å› æœå˜å¼‚å®šä½å¸®åŠ©å¾ˆå¤§ï¼›  
  - æ„å»ºè·¨äººç¾¤ PRSï¼ˆå¦‚ PRS-CSx æˆ–å…¶ä»–æ•´åˆæ–¹æ³•ï¼‰æ¯”å•ä¸€ PRS æ›´ç¨³å®š / æ›´æœ‰æ¨å¹¿æ€§ï¼›  
  - åœ¨é£é™©åˆ†å±‚ / å‘ç—…å¹´é¾„ /é¢„æµ‹æ¨¡å‹å±‚é¢è¯„ä¼° PRS çš„ä¸´åºŠæ„ä¹‰æ˜¯å¾ˆæœ‰ä»·å€¼çš„é™„åŠ åˆ†æï¼›  
  - åœ¨ä¼˜å…ˆåŸºå› å±‚é¢ï¼Œå¯ä»¥ç»“åˆå¤šç»„å­¦æ³¨é‡Šï¼ˆå¦‚ eQTLã€è¡¨è§‚æ³¨é‡Šï¼‰å¯¹å€™é€‰åŸºå› åšåŠ æƒæ³¨é‡Šã€‚

---

## ğŸ“š äº”ã€å‚è€ƒå¼•ç”¨
> Cao, X., Jiang, M., Guan, Y., et al (2025). *Trans-ancestry GWAS identifies 59 loci and improves risk prediction and fine-mapping for kidney stone disease.* *Nature Communications*, 16, 3473. DOI: 10.1038/s41467-025-58782-7
---

*æœ€åæ›´æ–°ï¼š2025-10-17*
